SJM

J.M. Smucker Reports 18% Rise in Q1 Net Sales

The J.M. Smucker Co. (NYSE: SJM) has reported its fiscal 2025 first-quarter results, showing a notable increase in net sales and adjusted earnings per share. The company's net sales for the first quarter ended July 31, 2024, were $2.1 billion, reflecting an 18% increase from the previous fiscal year. Excluding the impact of acquisitions, divestitures, and foreign currency exchange, net sales still showed a 1% increase.

Adjusted earnings per share for the quarter stood at $2.44, marking a 10% increase from the prior year. However, net income per diluted share was reported at $1.74, showing a slight decrease of 3% compared to the previous year.

The company's cash provided by operations was $172.9 million, down from $217.9 million in the prior year. Additionally, free cash flow decreased to $49.2 million from $67.6 million in the prior year.

In terms of the company's full-year fiscal 2025 outlook, J.M. Smucker Co. updated its guidance. It now expects a net sales increase of 8.5% to 9.5% compared to the prior year. The adjusted earnings per share are anticipated to range from $9.60 to $10.00, and free cash flow is expected to be approximately $875 million.

Looking at the segment results, the U.S. retail coffee segment saw a slight 1% increase in net sales, while the U.S. retail frozen handheld and spreads segment experienced a 7% increase. However, the U.S. retail pet foods segment reported a 9% decrease in net sales. The international and away from home segment also showed a 1% decrease in net sales.

The financial results and management discussion for the first quarter can be accessed through the company's website.

These results demonstrate the company's performance in a dynamic consumer environment and provide insights into its strategic initiatives and financial outlook for the fiscal year. Today the company's shares have moved -0.5% to a price of $120.7. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS